Chondrogenesis involves the transition of mesenchymal cells to cartilage through a process of condensation, followed by dramatic changes in the composition of the extracellular matrices produced by the cells. The ECM glycoprotein fibronectin is present in both the mesenchymal cell and the differentiated cartilage, but the isoforms produced by the cells differ due to a change in alternative mRNA splicing. Mesenchymal fibronectin contains both alternative segments EIIIA and EIIIB, which are encoded by the eponymous exons, whereas cartilage FN lacks the EIIIA domain, due to skipping of exon EIIIA by the splicing apparatus. Evidence suggests that the mesenchymal isoform of FN plays a role in the process of chondrogenic condensation, and it has been hypothesized that the subsequent loss of EIIIA is necessary for chondrogenic differentiation. An understanding of the mechanisms that regulate alternative splicing of the exon encoding EIIIA should permit experimental manipulation of splicing and so establish the roles of the various FN isoforms.
Three aims are proposed to achieve these goals. First, cellular factors that interact with exon EIIIA will be identified by screening for sequence-specific RNA-protein interactions. The functional relevance of any such interactions will be established by co-transfection of cells with an exon EIIIA splicing reporter and an expression construct for each candidate RNA binding protein. Second, knowledge of the cis sequences and trans factors important for exon EIIIA recognition will be used to develop novel methods to perturb exon EIIIA splicing, by forcing exon inclusion or exclusion irrespective of cell type. Last, agents that perturb exon EIIIA splicing will be applied to a micromass model of chondrogenic condensation, to establish the roles of the FN isoforms in undifferentiated mesenchyme or differentiated chondrocytes. These studies will increase understanding of the early stages of cartilage formation, with implications for normal embryonic development as well as for bone replacement in adults.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR046821-01
Application #
6090287
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Tyree, Bernadette
Project Start
2000-04-07
Project End
2003-03-31
Budget Start
2000-04-07
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$261,555
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Han, Fei; Gilbert, James R; Harrison, Gerald et al. (2007) Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation. Exp Cell Res 313:1518-32
Liang, Hongyan; Tuan, Rocky S; Norton, Pamela A (2007) Overexpression of SR proteins and splice variants modulates chondrogenesis. Exp Cell Res 313:1509-17
Han, Fei; Adams, Christopher S; Tao, Zhuliang et al. (2005) Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression. J Cell Biochem 95:750-62
Flanagan, Matthew; Liang, Hongyan; Norton, Pamela A (2003) Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences. J Cell Biochem 90:709-18
Kuo, Bruce A; Uporova, Tatiana M; Liang, Hongyan et al. (2002) Alternative splicing during chondrogenesis: modulation of fibronectin exon EIIIA splicing by SR proteins. J Cell Biochem 86:45-55
Seghatoleslami, M Reza; Tuan, Rocky S (2002) Cell density dependent regulation of AP-1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells. J Cell Biochem 84:237-48